Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...
SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — New global initiative urges patients and clinicians to wait for biomarker testing results ...
Emerging discoveries in liquid biomarker research promise to transform early detection, diagnosis, and treatment monitoring of colorectal cancer (CRC), according to a new study, offering less invasive ...
With more than 150,000 new colorectal cancer cases diagnosed annually in the United States, metastatic colorectal cancer (mCRC) remains an area of significant unmet medical need.
Prognostic biomarkers in colorectal cancer encompass a diverse array of molecular, cellular and systemic indicators that predict patient outcomes, guide therapeutic decisions and illuminate underlying ...
Dr. John Marshall explains why biomarker testing should be done early in colorectal cancer to guide treatment and identify targeted therapies. Biomarker testing is no longer optional in colorectal ...
New study uncovers how SOX4-activated lncRNA disrupts the PUF60-FUBP1 complex to drive c-MYC transcription and tumor ...
The Hearty Soul on MSN
Newly discovered virus linked to colorectal cancer
A previously unknown virus found inside a common gut bacterium appears at twice the rate in colorectal cancer patients The ...
New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment. SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results